Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intema is a Russian biotechnology and pharmaceutical company specializing in the development and production of original medicinal products based on synthetic peptides and recombinant proteins. The company's flagship products include Gepon, a synthetic peptide with immunomodulatory and antiviral properties, and Rexod, a recombinant human superoxide dismutase used for its potent antioxidant and anti-inflammatory effects. Intema focuses on therapeutic areas such as immunology, infectious diseases, and inflammatory conditions. Based in Moscow, the company maintains a presence in the Russian pharmaceutical market through its proprietary research and manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intema.